Acurx制药公司批准为国库购买多达100万美元的比特币。 Acurx Pharmaceuticals approves up to $1 million in Bitcoin purchases for its treasury.

Acurx制药公司是一家生物制药公司,已核准以比特币购买100万美元作为国库储备资产。 Acurx Pharmaceuticals, a biopharmaceutical company, has approved purchasing up to $1 million in Bitcoin as a treasury reserve asset. CEO David P. Luci强调,Bitcoin供应有限和对通货膨胀的抵制是关键因素。 CEO David P. Luci highlighted Bitcoin’s limited supply and resistance to inflation as key factors. 这项金融行动不影响该公司为治疗困难细菌感染而正在进行的抗生素发展努力。 This financial move does not affect the company’s ongoing antibiotic development efforts aimed at treating difficult bacterial infections.